Hematological Abnormalities in Culture Positive Neonatal Sepsis.
Ethiopia
Gondar
anemia
hematological abnormalities
neonatal sepsis
Journal
Pediatric health, medicine and therapeutics
ISSN: 1179-9927
Titre abrégé: Pediatric Health Med Ther
Pays: New Zealand
ID NLM: 101655856
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
02
2022
accepted:
30
05
2022
entrez:
14
6
2022
pubmed:
15
6
2022
medline:
15
6
2022
Statut:
epublish
Résumé
In neonatal sepsis, anemia, leukocytosis, thrombocytopenia, and a shortened coagulation time are the most common hematologic abnormalities. However, there is inadequate information regarding the hematological abnormalities in neonatal sepsis. Thus, we aimed to determine the magnitude of hematological abnormalities in neonatal sepsis. This is a cross-sectional study that included 143 neonates with culture proven sepsis aged 1-28 days from September 2020 to November 2021 at the University of Gondar Specialized Referral Hospital. The sociodemographic data was collected using a pre-tested structured questionnaire, and the clinical and laboratory data was collected using a data collection sheet. A total of 2 mL of venous blood was taken using a vacutainer collection device for the complete blood count (CBC) and blood culture analysis. A univariate and multivariate logistic regression model was used to investigate factors associated with hematological abnormalities in neonatal sepsis. Statistical significance was declared when a p-value was less than 0.05. The prevalence of anemia, thrombocytopenia, and leucopenia in neonatal sepsis was 49% (95% CI: 40.89-57.06), 44.7% (95% CI: 36.8-52.9), and 26.6% (95% CI: 22.01-29.40), respectively. On the other hand, leukocytosis and thrombocytosis were found in 7.7% (95% CI: 4.35-13.25) and 11.9% (95% CI: 7.56-18.21), respectively. Being female (AOR: 3.3; 95% CI: 1.20-3.82) and being aged less than 7 days (AOR: 2.44; 95% CI: 1.6-6.9) were found to be significant predictors of anemia. The magnitude of anemia, leucopenia, and thrombocytopenia is high in neonatal sepsis. Furthermore, being female and being younger than 7 days were risk factors for anemia. Thus, the diagnosis and treatment of anemia, leucopenia, and thrombocytopenia prevents further complications in neonatal sepsis.
Sections du résumé
Background
UNASSIGNED
In neonatal sepsis, anemia, leukocytosis, thrombocytopenia, and a shortened coagulation time are the most common hematologic abnormalities. However, there is inadequate information regarding the hematological abnormalities in neonatal sepsis. Thus, we aimed to determine the magnitude of hematological abnormalities in neonatal sepsis.
Methods
UNASSIGNED
This is a cross-sectional study that included 143 neonates with culture proven sepsis aged 1-28 days from September 2020 to November 2021 at the University of Gondar Specialized Referral Hospital. The sociodemographic data was collected using a pre-tested structured questionnaire, and the clinical and laboratory data was collected using a data collection sheet. A total of 2 mL of venous blood was taken using a vacutainer collection device for the complete blood count (CBC) and blood culture analysis. A univariate and multivariate logistic regression model was used to investigate factors associated with hematological abnormalities in neonatal sepsis. Statistical significance was declared when a p-value was less than 0.05.
Results
UNASSIGNED
The prevalence of anemia, thrombocytopenia, and leucopenia in neonatal sepsis was 49% (95% CI: 40.89-57.06), 44.7% (95% CI: 36.8-52.9), and 26.6% (95% CI: 22.01-29.40), respectively. On the other hand, leukocytosis and thrombocytosis were found in 7.7% (95% CI: 4.35-13.25) and 11.9% (95% CI: 7.56-18.21), respectively. Being female (AOR: 3.3; 95% CI: 1.20-3.82) and being aged less than 7 days (AOR: 2.44; 95% CI: 1.6-6.9) were found to be significant predictors of anemia.
Conclusion
UNASSIGNED
The magnitude of anemia, leucopenia, and thrombocytopenia is high in neonatal sepsis. Furthermore, being female and being younger than 7 days were risk factors for anemia. Thus, the diagnosis and treatment of anemia, leucopenia, and thrombocytopenia prevents further complications in neonatal sepsis.
Identifiants
pubmed: 35698626
doi: 10.2147/PHMT.S361188
pii: 361188
pmc: PMC9188337
doi:
Types de publication
Journal Article
Langues
eng
Pagination
217-225Informations de copyright
© 2022 Adane et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest in relation to this work and that there is no conflict of interests regarding the publication of this manuscript.
Références
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Semin Respir Crit Care Med. 2004 Dec;25(6):645-59
pubmed: 16088507
Jpn J Infect Dis. 2007 May;60(2-3):126-8
pubmed: 17515647
Front Med (Lausanne). 2021 Jun 11;8:634349
pubmed: 34179032
Inflammation. 2018 Oct;41(5):1569-1581
pubmed: 29956069
Antimicrob Agents Chemother. 2002 May;46(5):1481-91
pubmed: 11959586
Int J Mol Sci. 2019 Jul 16;20(14):
pubmed: 31315248
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
BMJ. 2020 Oct 1;371:m3672
pubmed: 33004379
J Int Med Res. 2020 Sep;48(9):300060520952275
pubmed: 32962507
Int J Pediatr. 2020 Apr 15;2020:6468492
pubmed: 32351579
BMC Pediatr. 2020 Sep 2;20(1):417
pubmed: 32878611
JAMA. 2004 Nov 17;292(19):2357-65
pubmed: 15547163
Medicine (Baltimore). 2021 May 7;100(18):e25013
pubmed: 33950914
PLoS One. 2017 Oct 4;12(10):e0185581
pubmed: 28977011
J Pediatr. 1974 Sep;85(3):415-9
pubmed: 4610423
Diagnostics (Basel). 2021 Oct 12;11(10):
pubmed: 34679578
Ann Trop Paediatr. 2006 Dec;26(4):311-8
pubmed: 17132296
PLoS One. 2019 Oct 17;14(10):e0223553
pubmed: 31622365
BMJ Glob Health. 2018 Jan 12;3(1):e000347
pubmed: 29564153
Semin Thromb Hemost. 2016 Apr;42(3):252-7
pubmed: 26926582
Indian J Hematol Blood Transfus. 2012 Sep;28(3):147-51
pubmed: 23997450
Front Microbiol. 2020 Jun 19;11:1375
pubmed: 32636828
Pediatr Res. 2022 Jan;91(2):337-350
pubmed: 34728808
Med Princ Pract. 2007;16(5):344-7
pubmed: 17709921
Afr Health Sci. 2019 Sep;19(3):2390-2399
pubmed: 32127809
Transfus Med Hemother. 2012 Oct;39(5):353-61
pubmed: 23801928
Infect Control Hosp Epidemiol. 2011 Jul;32(7):679-86
pubmed: 21666399
J Infect. 2014 Jan;68 Suppl 1:S24-32
pubmed: 24140138
JAMA. 2002 Sep 25;288(12):1499-507
pubmed: 12243637
Lancet. 2017 Oct 14;390(10104):1770-1780
pubmed: 28434651
Int J Mol Sci. 2017 Sep 08;18(9):
pubmed: 28885563
Turk Pediatri Ars. 2018 Dec 25;53(Suppl 1):S88-S100
pubmed: 31236022
Pediatrics. 2011 May;127(5):817-26
pubmed: 21518717